FRO Frontline PLC
- 25.730
- +0.430+1.70%
- 25.790
- +0.060+0.23%
Frontline PLC News
Here's Why Frontline (NYSE:FRO) Has Caught The Eye Of Investors
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage to find investors.
FRO – Filing of Annual Report
Frontline plc (the "Company") announces the filing of its annual report for the year ended December 31, 2023.The annual report can be downloaded from the Company's website www.frontlineplc.cy or from
Frontline Plc's (NYSE:FRO) Business And Shares Still Trailing The Market
Frontline plc's (NYSE:FRO) price-to-earnings (or "P/E") ratio of 7.8x might make it look like a strong buy right now compared to the market in the United States, where around half of the companies hav
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ:ELVN) rose sharply during Thursday's session. Enliven Therapeutics an
S&P 500 Futures Fall In Premarket Trading; CarMax, Fastenal Lag
This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, Blueprint Medicines Corp. (BPMC) was up 5.9% in pre
Frontline Plc (NYSE:FRO) Surges 3.8%; Retail Investors Who Own 39% Shares Profited Along With Insiders
Is FRONTLINE PLC (FRO) a Buy as Wall Street Analysts Look Optimistic?
Frontline, DHT Raised to Buy at Jefferies With Oil Market Shifting Favorably
Deep Dive Into Frontline Stock: Analyst Perspectives (5 Ratings)
Ratings for Frontline (NYSE:FRO) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.In the table below, you'll find a summary of their recent ra
Is Frontline Plc (NYSE:FRO) Trading At A 31% Discount?
Key Insights Frontline's estimated fair value is US$32.78 based on 2 Stage Free Cash Flow to Equity Frontline's US$22.64 share price signals that it might be 31% undervalued Our fair value estimat
Micron To Rally Around 134%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Rosenblatt
Frontline Raised to Buy From Hold by Jefferies
Frontline Raised to Buy From Hold by Jefferies
Jefferies Upgrades Frontline to Buy, Raises Price Target to $30
Jefferies analyst Omar Nokta upgrades Frontline (NYSE:FRO) from Hold to Buy and raises the price target from $22 to $30.
Frontline (NYSE:FRO) Shareholder Returns Have Been Massive, Earning 437% in 5 Years
The 4.6% Return This Week Takes Frontline's (NYSE:FRO) Shareholders Five-year Gains to 429%
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But when you pick a company that is really flourishing, you can make mo
A Look At The Intrinsic Value Of Frontline Plc (NYSE:FRO)
Frontline PLC To Go Ex-Dividend On March 14th, 2024 With 0.37 USD Dividend Per Share
March 2nd - $Frontline PLC(FRO.US)$ is trading ex-dividend on March 14th, 2024. Shareholders of record on March 15th, 2024 will receive 0.37 USD dividend per share on March 27th, 2024. The ex-divi
Forecasting The Future: 4 Analyst Projections For Frontline
In the last three months, 4 analysts have published ratings on Frontline (NYSE:FRO), offering a diverse range of perspectives from bullish to bearish.The following table encapsulates their recent rati
Frontline Price Target Cut to $22.30/Share From $23.00 by JP Morgan
Frontline Price Target Cut to $22.30/Share From $23.00 by JP Morgan
JP Morgan Maintains Neutral on Frontline, Lowers Price Target to $22.3
JP Morgan analyst Samuel Bland maintains Frontline (NYSE:FRO) with a Neutral and lowers the price target from $23 to $22.3.
Analysis
Price Target
No Data
